After only two years .. Provide a vaccine to prevent all strains of influenza
After only two years .. Provide a vaccine to prevent all strains of influenza
Millions of people are infected with the flu every year, which will become a thing of the past after just two years, after the invention of a vaccine protected from all strains of influenza for up to ten years.
The results of the human trial in the UK today suggest that the vaccine is more effective than existing vaccines that target only a few types of the virus.
Researchers who invented the vaccine claim that it will end the global flu pandemic and turn into a mild disease rather than a killer.
FLU-v jab, a work of British company Emotix, is said to be resistant to every strain of the annual winter virus to malignant strains such as swine flu and the recent Australian flu.
The cost is likely to range from £ 20 to £ 50 per person, but it should be awarded every five to 10 years only.
The current vaccines target the proteins on the surface of the virus, but the regions of these proteins are constantly changing in an attempt to deceive the immune system, meaning that the virus is always ahead of the vaccine, and that is why it needs to be renewed every year.
The new FLU-v jab vaccine was created to target unchanging areas of virus proteins by promoting T cells in the immune system that recognize and attack foreign viruses.
After only two years .. Provide a vaccine to prevent all strains of influenza
Millions of people are infected with the flu every year, which will become a thing of the past after just two years, after the invention of a vaccine protected from all strains of influenza for up to ten years.
The results of the human trial in the UK today suggest that the vaccine is more effective than existing vaccines that target only a few types of the virus.
Researchers who invented the vaccine claim that it will end the global flu pandemic and turn into a mild disease rather than a killer.
FLU-v jab, a work of British company Emotix, is said to be resistant to every strain of the annual winter virus to malignant strains such as swine flu and the recent Australian flu.
The cost is likely to range from £ 20 to £ 50 per person, but it should be awarded every five to 10 years only.
The current vaccines target the proteins on the surface of the virus, but the regions of these proteins are constantly changing in an attempt to deceive the immune system, meaning that the virus is always ahead of the vaccine, and that is why it needs to be renewed every year.
The new FLU-v jab vaccine was created to target unchanging areas of virus proteins by promoting T cells in the immune system that recognize and attack foreign viruses.